Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP adjunctive treatment for frontal fibrosing alopecia
TCTR20231021001Phase 2Unknown
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Nov 2023
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous platelet-rich plasma in frontal fibrosing alopecia (FFA) (2 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Primary endpoint: Sign of inflammation. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
frontal fibrosing alopecia (FFA)
Beyond the preview
Go deeper on TCTR20231021001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231021001.